Philadelphia Phillies outfielder Max Kepler received an 80-game suspension from Major League Baseball on Friday for violating the league’s joint drug prevention and treatment program, as announced by the league.
Kepler’s Suspension: A Blow to Free Agency Prospects
The 32-year-old tested positive for Epitrenbolone, a performance-enhancing substance.
- Kepler appeared in 127 games for the Phillies during the 2025 season.
- He hit .216 with 18 home runs and 52 RBI.
- The suspension includes ineligibility for the 2026 postseason.
- Prior to the announcement, a return to the Phillies was considered unlikely.
The suspension throws Kepler’s future into uncertainty as he navigated free agency. He finished the 2025 season with a .216 batting average, 18 home runs, 19 doubles, and 52 runs batted in across 127 games with the Phillies. His on-base plus slugging percentage (.OPS) was .691.
A Shifting Landscape for Kepler
Before Friday’s news, a reunion with the Phillies appeared improbable, according to Cole Weintraub of NBC Sports Philadelphia. Interest from the Kansas City Royals had also been reported by Ken Rosenthal of The Athletic earlier in the offseason.
Kepler spent the first decade of his Major League Baseball career with the Minnesota Twins before joining the Phillies for the 2025 campaign. During his time in Minnesota, he maintained a .237 batting average, a .318 on-base percentage, and a .429 slugging percentage. He demonstrated consistent power, reaching at least 19 home runs in five separate seasons.
Minnesota Memories
His most productive year came in 2019, when he posted an .855 OPS, hitting a career-high 36 home runs and driving in 90 runs over 134 games. The suspension casts a shadow over those past accomplishments and raises questions about his future on the field.
In addition to the 80-game suspension, Kepler will be ineligible to participate in the 2026 postseason should he sign with a team.
